HomeTOP STORIESAstraZeneca Non-GAAP EPS of $2.49, revenue of $13.59B AstraZeneca Non-GAAP EPS of $2.49, revenue of $13.59B By rogerjudd April 29, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleBP Non-GAAP EPADS of $0.53 misses by $0.03, revenue of $46.91B beats by $7.03BNext articleWhat We Know About the Power Outages in Spain and Portugal latest articles U.S. Bancorp Q4 earnings reflect strong deposits, fee income; 2026 guidance in line 908 Devices shares jump on preliminary Q4 and FY25 financial update Netflix Revamps Its Warner Bros. Bid, Seeking to Thwart Paramount VCI Global stock dips on $5M securities offering Greenland tariff battle will cause market weakness: Wedbush 2026 Oscar Nomination Predictions explore more U.S. Bancorp Q4 earnings reflect strong deposits, fee income; 2026 guidance in line 908 Devices shares jump on preliminary Q4 and FY25 financial update Netflix Revamps Its Warner Bros. Bid, Seeking to Thwart Paramount VCI Global stock dips on $5M securities offering Greenland tariff battle will cause market weakness: Wedbush 2026 Oscar Nomination Predictions
